🔥Module 2 is available!
Continue our series of interactive e-learning modules that guide you in the diagnosis and management of #CKD patients.
🎯Module 2 focuses on the critical steps of diagnosing and initiating treatment of CKD.
Start Module 2👉 https://t.co/2aLv2YdLOS
🚨 Attention! We want to hear from you. At Science Collected, we value your input to shape our educational offerings.
How do you prefer to learn? Share your insights.
Have a new idea or suggestion? Leave a comment! We are all ears.
#MedTwitter#MedEd
🎙️2 podcasts, 1 goal: Answers in 6 minutes.
3 critical steps in 3 months to save #CKD lives. How?
eGFR dip and #SGLT2 inhibitors — any concern?
Explore 2 podcasts with Prof. David Cherney & @kieranmccaffs on kidney care & SGLT2 inhibitors.
🎧Listen 👉 https://t.co/HunTeUu5WF
📊 Explore our insightful infographic on SGLT2 inhibitors' role in #hypertension, #CKD, #HF & #T2D management based on the latest #ESH2023 guidelines.
🔗 Attached here 👉 https://t.co/aIwkFs5DEf
🔥Module 1 is out!
Our 3 interactive e-learning modules guide you through the steps from the diagnosis and management of the #CKD patients.
🎯 Module 1 covers the steps to take for screening a patient with a risk of CKD.
Start now 👉 https://t.co/Fkp5zmywI4
#MedEd
🔥Exciting news! Our expert-led educational presentations are now available!
📚Visualise your learning with engaging visuals and key points.
🔎Discover a goldmine of knowledge in #renal , #cardiovasvular, #rare and #metabolic diseases.
👉https://t.co/xGeByN5OYY
Nephrologists provide vital cardiorenal protection to #CKD patients, while primary care physicians play a key role in early CKD detection.
The common goal: Better #patient outcomes.
Curious about this collaboration in CKD care?
Watch👉https://t.co/1Xd2x7IqsC
#nephwitter
26/ You’ve reached the end of this tweetorial! 🙌 You can view the full #DUKPC2023 symposium recording on the @ScienceCollect1 educational platform at https://t.co/A37MrRaqhy. We also encourage you to catch our #podcast series. See you there!
1/ Welcome to the official tweetorial for ‘Optimising lipid control in diabetes – the rise of omega-3 fatty acids’! We’ll recap the key messages from this #DUKPC symposium featuring @drsarahjdavies, @drnkan and Dr Handrean Soran.
#T2D#lipid#CVD#DUKPC2023
25/ CV health should be at the forefront of #T2D management. Residual #CVD risk remains high for people with T2D despite current #lipid-lowering therapies. #Omega3 fatty acid research may lead to T2D therapy evolution using a holistic cardiorenal-metabolic approach.